Skip to Main Content

Recombinant human serum albumin (rHSA)

Optibumin® 25

Product Number 777HSA106
Form 25% w/v Liquid
Origin Animal-Origin Free
Status GMP, Excipient

High-purity, GMP excipient, recombinant albumin supplied as a 25% w/v solution in bottles and closed-system bags for advanced biomanufacturing and therapeutics.

Designed as a drop-in 25% replacement for plasma-derived HSA, with no reformulation required.

100 mL Bottle
$785.00
100 mL Bag
$785.00

Composition

Form
Liquid
Purity
≥99.0%
Endotoxin
≤0.02 EU/mg
Stabilizers
No stabilizers or preservatives
Storage
2 to 8 °C

Compliance

Status
AOF, Excipient
Manufacturing
cGMP, ISO 9001:2015
Facility
Junction City, KS
Documentation
Lot-specific CoA
View complete specifications

Product overview

A recombinant 25% drop-in for plasma HSA.

Until now, biomanufacturing teams running 25% human serum albumin have had no practical options for recombinant excipient alternatives that don’t require reconstitution.

Optibumin® 25 closes the gap. A 25% w/v excipient recombinant human serum albumin produced in a non-mammalian system, manufactured cGMP at InVitria’s ISO 9001:2015 facility in Junction City, KS, it matches the 25% concentration of plasma-derived HSA exactly, so existing CryoStor and Plasma-Lyte workflows do not need to be redesigned to qualify it. Across 10 to 15 production lots it shows less than 0.5% total aggregates and roughly 99% reduced Cys34, with inter-lot standard deviations roughly ten times tighter than plasma HSA. It carries no caprylate or N-acetyl tryptophan, is animal-origin-free, plasma-free, and pathogen-free, and ships in 100 mL closed-system friendly bags and 100 mL bottles.

From InVitria application notes

See the Data at a Glance

Infectious lentiviral vector titer during a room-temperature hold with 0%, 2% or 8% Optibumin 25, third-party collaborator data

Fig. 1 · LVV room-temperature hold

Infectious LVV titer held through 24 hours at room temperature

In third-party collaborator data, VSV-G pseudotyped LVV held at 21 °C without albumin fell below the limit of quantitation by 24 hours. With 2% Optibumin® 25, infectivity was fully preserved through the first 10 hours, ~86% of titer remained at 24 hours, and usable stability extended to 48 hours.

View the ASGCT 2026 presentation →
Post-thaw proliferation over 72 hours of donor 1 T cells cryopreserved in CryoStor CS10 or CS5 with 0%, 5% or 10% Optibumin or blood-derived HSA

Fig. 2 · T cell recovery at reduced DMSO

Stronger T cell recovery at as little as 3% DMSO

In CryoStor® CS5 with 10% Optibumin® 25 (3% final DMSO), post-thaw T cells expanded 1.6-fold over 72 hours, significantly more than with blood-derived HSA, which tracked close to the no-albumin control. In CS10, 10% Optibumin® 25 roughly doubled viable cells. Donor 1 shown; a second donor showed the same trend.

Read the application note →
Genomic and infectious lentiviral vector titer after 0.2 micron PES sterile filtration in HBSS alone or with 1% Optibumin 25

Fig. 3 · Sterile filtration

~3× the infectious titer through a 0.2 µm filter

A 5-minute 1% Optibumin® 25 pre-coat passivates the PES membrane before sterile filtration. Infectious titer recovery was ~3× that of HBSS-only filtration and ~4× more genomic titer was retained, with the infectious-to-genomic ratio preserved at 0.36%.

Read the application note →

Featured Resources

The published data behind the claims

Partner: Merck

Technical Attributes

Attribute Value
Physical & Chemical
Form Liquid
Formulation Buffered salt-based solution
SKU / Product Number 777HSA106
Storage 2 to 8 °C
Concentration 250 mg/mL (25% w/v)
Purity ≥99.0%
Status Recombinant, Animal-Origin Free
Aggregates <0.5% by SEC-HPLC
Reduced Cys34 (free thiol) ~99% by HPLC
Shelf life 3 years from DOM
Composition
Stabilizers/Preservatives None
Packaging 100 mL closed-system friendly bag · 100 mL bottle
Regulatory
Sterility Sterile (0.2 µm sterile filtered)
Endotoxin level ≤0.02 EU/mg
Manufacturing cGMP-compliant. ISO 9001:2015-certified facility, Junction City, KS, USA
Documentation Lot-specific Certificate of Analysis · Data Sheet · Guidelines for Use

Key Benefits

Drop-in 25% replacement for plasma HSA
Optibumin® 25 matches the 25% w/v of plasma HSA, in 100 mL closed-system bags or bottles.
Up to 40% Less DMSO
Adding 5 to 10% Optibumin 25 to CryoStor CS10 brings final DMSO to 6%. CS5 + 5% Optibumin 25 holds T-cell post-thaw viability at 90% or higher.
Tight Lot-to-Lot Consistency
<0.5% aggregates and ~99% reduced Cys34, with about 10x lower lot-to-lot variability than plasma HSA.
Animal-Free, No Added Stabilizers
Blood-free and animal-origin-free. No preservatives, sodium octanoate (caprylate), or N-acetyl tryptophan.
Closed-system friendly format
100 mL bags engineered for sealed-system biomanufacturing. Integrates into closed-system cGMP cell-therapy workflows without open-handling.

How to order Optibumin 25

Catalog purchase
$785 per unit for the 100 mL closed-system bag or 100 mL bottle, available on the InVitria catalog with direct checkout.
Purchase Order
Contact info@invitria.com or a Product Applications team member at InVitria to submit a PO directly.
Bulk pricing
Liter quantities for late-stage clinical and commercial manufacturing. Tell us your quantity, order frequency, and manufacturing schedule in the bulk pricing form so supply matches your demand.
Regional distribution
Optibumin 25 is available worldwide. Most customers work directly with InVitria for full portfolio access and bulk and commercial-scale supply. European customers can order with direct fulfillment from InVitria’s Rotterdam, Netherlands facility. To buy through a regional distributor, use the Find a Distributor form.

Common questions

Peer-Reviewed Publications

Optibumin® 25 is built for these applications

Compare across the rHSA family

 
Concentration Lyophilized powder, reconstitute to 10 to 20% w/v 25% w/v sterile liquid 20% w/v sterile liquid Lyophilized powder, reconstitute to 10 to 20% w/v 25% w/v sterile liquid
Format 10 g, 100 g + scale 100 mL closed-system bag, 100 mL bottle + scale 100 mL and 1 L bottles 10 g, 100 g + scale 100 mL bottle + scale
Best for Serum-free cell culture media supplementation Injectable final-formulation excipient. Closed-system applications; 25% drop-in for plasma HSA Injectable final-formulation excipient. 20% drop-in for plasma HSA Injectable excipient rHSA for final formulation where lyophilized powder is preferred. Stem cell culture (iPSC/MSC/etc), lipid sensitive cell types, In Vitro Fertilization (IVF)
Grade GMP GMP, Excipient GMP, Excipient GMP, Excipient GMP
  Explore Cellastim S Explore Optibumin 25 Explore Optibumin 20 Explore Exbumin Explore Optibumin X